We are live on
!
Find out more
TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
62 hedge funds and large institutions have $105M invested in Taro Pharmaceutical Industries Ltd. in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 71 → 62 (-9)
19% less capital invested
Capital invested by funds: $130M → $105M (-$25M)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
Holders
62
Holders Change
-9
Holders Change %
-12.68%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
20
Reduced
19
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.84M |
| 2 |
CAC
Cowen and Company
New York
|
+$2.09M |
| 3 |
KAM
Krensavage Asset Management
New York
|
+$1.89M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$1.21M |
| 5 |
SFO
Stokes Family Office
New Orleans,
Louisiana
|
+$314K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$7.36M |
| 2 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$2.06M |
| 3 |
Renaissance Technologies
New York
|
-$1.04M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.02M |
| 5 |
Millennium Management
New York
|
-$386K |
